Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0G2MR
|
||||
Former ID |
DIB013011
|
||||
Drug Name |
ProstaVac
|
||||
Synonyms |
ProstaVac; Pox virus vector prostate specific antigen vaccine (benign prostatic hyperplasia/prostatitis); Pox virus vector prostate specific antigen vaccine (benign prostatic hyperplasia/prostatitis), AmVac
|
||||
Drug Type |
Vaccine
|
||||
Indication | Prostate hyperplasia [ICD10:N40] | Phase 3 | [544259] | ||
Company |
AmVac AG
|
||||
Target and Pathway | |||||
Target(s) | Prostate specific antigen | Target Info | [543613] | ||
KEGG Pathway | Pathways in cancer | ||||
Prostate cancer | |||||
Pathway Interaction Database | Coregulation of Androgen receptor activity | ||||
Regulation of Androgen receptor activity | |||||
FOXA1 transcription factor network | |||||
WikiPathways | Prostate Cancer | ||||
Androgen receptor signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.